跨境资本监管
Search documents
上市公司有棵树大股东自恃境外身份失约重整承诺且涉嫌多项违规
Sou Hu Cai Jing· 2025-09-26 06:35
Core Viewpoint - The recent issues surrounding Youkeshu Technology Co., Ltd. (stock code: 300209) involve allegations against major shareholder Wang for shareholding violations, insider trading, and failure to fulfill restructuring commitments, prompting regulatory scrutiny [1][7]. Regulatory Background: Allegations of Violations - Allegations include shareholding violations, with Wang suspected of holding shares through a foreign entity and failing to disclose this relationship, which complicates regulatory oversight [1][2]. - A transfer of 19.5 million yuan from Liu to a company controlled by Wang is viewed as suspicious, indicating potential shareholding violations and misleading disclosures [2][4]. - Wang and Liu's denial of a concerted action relationship raises concerns about the accuracy of previous disclosures, which could lead to legal repercussions [3][4]. Specific Allegations - Allegation of 2.14 million shares being illegally reduced by Liu, who failed to comply with mandatory disclosure requirements for major shareholders [4][5]. - The stock price of Youkeshu experienced unusual fluctuations, with a significant increase prior to the announcement of a shareholder meeting, raising suspicions of insider trading [5][6]. Restructuring Commitments - Wang and Shenzhen Tianmouyun's failure to fulfill commitments made during the bankruptcy restructuring process has led to significant operational challenges for Youkeshu, including an 81.33% year-on-year revenue decline [7][8]. - Regulatory bodies are questioning the validity of Wang's claims regarding the failure of preconditions for these commitments [9]. Legitimacy of Shareholder Meeting - The legality of the shareholder meeting called by Wang is under scrutiny, with concerns about compliance with corporate governance rules [10]. - Stakeholders have requested regulatory investigations into the compliance of the restructuring commitments and the legitimacy of the shareholder meeting [10].